32 Stocks Moving In Monday's Mid-Day Session

Gainers

  • Aimmune Therapeutics Inc AIMT shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
  • Exactech, Inc. EXAC shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
  • Dextera Surgical Inc DXTR shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
  • Petmed Express Inc PETS jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
  • SenesTech Inc SNES shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
  • Yulong Eco-Materials Ltd YECO shares gained 18.3 percent to $0.560.
  • One Horizon Group Inc OHGI shares rose 18 percent to $1.18.
  • Atossa Genetics Inc ATOS shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
  • ReneSola Ltd. (ADR) SOL shares rose 15.3 percent to $2.72
  • Renren Inc RENN shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
  • Kalvista Pharmaceuticals Inc KALV shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
  • Xunlei Ltd XNET shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
  • VF Corp VFC shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
  • CAI International Inc CAI rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
  • Agenus Inc AGEN shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
  • Deltic Timber Corp DEL shares climbed 5.6 percent to $94.11 after Potlach announced plans to merge with Deltic.
  • Deciphera Pharmaceuticals Inc DCPH surged 4.3 percent to $21.00. JMP Securities initiated coverage on Deciphera Pharmaceuticals with a Market Outperform rating.
  • Pluristem Therapeutics Inc. PSTI shares climbed 3.4 percent to $1.83 after the company announced a European Patent for RLX-R18.

 

 

Losers

  • DBV Technologies SA - ADR DBVT shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
  • Connecture Inc CNXR shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
  • Walter Investment Management Corp WAC slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
  • Eldorado Gold Corp (USA) EGO shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
  • Seanergy Maritime Holdings Corp. SHIP shares fell 15.4 percent to $1.04.
  • Future Fintech Group Inc FTFT dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
  • Concordia International Corp CXRX shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
  • Aemetis Inc AMTX shares declined 11.3 percent to $0.550
  • OncoSec Medical Inc ONCS dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
  • Evoke Pharma Inc EVOK shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
  • Eiger Biopharmaceuticals Inc EIGR shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
  • Viking Therapeutics Inc VKTX shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo model of X-linked adrenoleukodystrophy.
  • Aerojet Rocketdyne Holdings, Inc. AJRD declined 6.5 percent to $32.19. Jefferies downgraded Aerojet Rocketdyne from Buy to Hold.
  • General Electric Company GE dropped 4.5 percent to $22.77. UBS downgraded General Electric from Buy to Neutral, while Morgan Stanley downgraded the stock from Equal-Weight to Underweight.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversInformation TechnologyIT Consulting & Other ServicesLosersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!